会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 36. 发明公开
    • 5,11-Dihydrodibenzo[b,e][1,4]-oxazepine derivatives as calcium channel antagonists
    • 5,11-二氢二苯并(e)-1,4-氧氮杂 - 维生素E钙钙拮抗剂
    • EP1471060A1
    • 2004-10-27
    • EP04014975.9
    • 2000-01-11
    • Ajinomoto Co., Inc.
    • Sakata, KatsutoshiTsuji, TakashiSasaki, NorikoTakahasi, Kazuyoshi
    • C07D267/18C07D413/04C07D413/14A61K31/553A61P1/00
    • C07D413/06C07D267/18C07D413/04C07D413/12C07D413/14
    • 5,11-Dihydrodibenzo[b,e][1,4]oxazepine derivatives of following general formula [Ib], stereoisomers thereof, pharmacologically acceptable salts thereof or hydrates thereof:
      wherein R 1 to R 5 may be the same or different from each other and they each represent hydrogen atom, a halogen atom, cyano group, hydroxyl group, a lower alkyl group, a lower alkoxyl group, amino group or a lower alkylamino group, or R 1 and R 2 , R 2 and R 3 , R 3 and R 4 or R 4 and R 5 together represent -O(CH 2 ) n O- group (n being 1, 2 or 3),
         A represents CH 2 , CHOH, CO or O, B represents CH 2 , CHOH or CO, or A-B represents CH=CH, and D represents CH 2 , CH 2 -CH 2 or CH 2 -CH 2 - CH 2 , or B-D represents CH 2 , and pharmaceutical compositions containing them are useful for treating or preventing abnormal motor functions of gastrointestinal tracts, particularly irritable bowel syndrome.
    • 二苯并[b,e] [1,4]氧氮杂衍生物(I)是新的。 式(I)的二苯并[b,e] [1,4]氧氮杂衍生物及其盐和水合物是新的。 [图] Q:CH2VDBAPh,V1DBAPh或CH2CH2N(R6)DBAPh; V:哌啶-1,2-二基,吗啉-3,4-二基,硫代吗啉-3,4-二基)或全部通过N连接到D的4-甲基 - 哌嗪-1,2-二基; 通过N连接到D的V1吡咯烷-1,3-二基; Ph:任选被1-5个卤素,CN,OH,低级烷基,低级烷氧基或低级烷基氨基取代的苯基,或被O(CH 2)n O取代在2个相邻的C上; n:1-3; R6H或低级烷基; A:CH2,CHOH,CO或O; B:CH 2,CHOH或CO; 或A + B:CH = CH; D:CH2,CH2CH2或CH2CH2CH2; 或BD:CH2。 活性:抗炎。 作用机制:钙拮抗剂。 在体外测定(R)-5,11-二氢-5- [1-(4-甲氧基苯乙基)吡咯烷-3-基]二苯并[b,e] [1,4]氧氮杂(Ia).HCl具有IC50值 对于大鼠血管和肠钙通道活性分别为92nM和18nM。